Date	Period	Revenue/Estimate	Earnings Call
Aug 8, 2024	2024/Q3	11.767B / 12.300B	--
May 9, 2024	2024/Q2	10.642B / 11.254B	--
Feb 8, 2024	2024/Q1	10.746B / 11.700B	--
Nov 9, 2023	2023/Q4	11.407B / 11.018B	--
Aug 8, 2023	2023/Q3	10.257B / 11.475B	--

DatePeriodRevenue/EstimateEarnings Call

Aug 8, 20242024/Q311.767B / 12.300B--

May 9, 20242024/Q210.642B / 11.254B--

Feb 8, 20242024/Q110.746B / 11.700B--

Nov 9, 20232023/Q411.407B / 11.018B--

Aug 8, 20232023/Q310.257B / 11.475B--

Unlock Free Earnings Estimates

Open Account

Fuji Pharma: Interim report.

Dec 22, 2024 22:46 ET

Fuji Pharma: Confirmation letter.

Dec 22, 2024 22:37 ET

Fuji Pharma: Financial Report - Term 60 (2023/10/01 - 2024/09/30)

Dec 22, 2024 22:32 ET

Fuji Pharma: Summary of Financial Results for the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)

Nov 12, 2024 02:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Nov 26, 2024

Strong Buy

No Data